Ewan talks about how one becomes a bioperl developer and how those invitations to hackathons get sorted out… http://bioperl.org/pipermail/bioperl-l/2003-February/011226.html

[Excerpt] …Bioperl hackers who have been at Singapore have been discussing the next generation of sequence feature handling.

About 30 open source informatics developers are hacking away in Singapore now working on various efforts. The main website is at http://hackathon.open-bio.org and contains links to the Blog site and the picture gallery.

Urgent notice –> Primary CVS server has been relocated to pub.open-bio.org “dev.open-bio.org” – our primary developer server is down in Boston with a corrupt password file.

Mark reports: Just noticed a little snippit about biojava in the latest issue of the scientist http://www.the-scientist.com/yr2003/jan/labcon_030127.html (free registration required to view the article)

Jason reports: Bioperl 1.2 was mentioned in ‘The Scientist’ (free registration required to read this link) http://www.the-scientist.com/yr2003/jan/labcon_030113.html

Thomas Down reports: We’ve had a number of requests recently for a more recent snapshot of the biojava-live code, so I’ve just put together a biojava-1.3pre1 release. Get source, binaries, and javadocs from: http://www.biojava.org/download/ This isn’t absolutely set in stone yet, but should give a reasonable indication of what the forthcoming 1.3 series is going to look like. All testing and comments welcome!

Mark Schreiber has posted more than 40 tutorials on using “biojava in anger” at http://bioconf.otago.ac.nz/biojava/

The 1.2 Bioperl release is now available from the usual location.

Site URL is: http://open-bio.org/bosc2002 and the pictures from the event are available at http://gallery.open-bio.org/gallery/bosc2001

August 2, 2002 Edmonton, Alberta, Canada Call to order Board members present: Hilmar, Chris, Ewan, Steven, Andrew Recognition of observers (about 21) This meeting was open to the the public. I don’t know all of the people who commented, hence the question marks.